Repurposing host-based therapeutics to control coronavirus and influenza virus
Sign Up to like & getrecommendations! Published in 2019 at "Drug Discovery Today"
DOI: 10.1016/j.drudis.2019.01.018
Abstract: The development of highly effective antiviral agents has been a major objective in virology and pharmaceutics. Drug repositioning has emerged as a cost-effective and time-efficient alternative approach to traditional drug discovery and development. This new… read more here.
Keywords: control; coronavirus influenza; drug; host based ... See more keywords
Cangma Huadu granules, a new drug with great potential to treat coronavirus and influenza infections, exert its efficacy through anti-inflammatory and immune regulation
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Ethnopharmacology"
DOI: 10.1016/j.jep.2021.114965
Abstract: Ethnopharmacological relevance Coronavirus and influenza virus infection seriously threaten human health. Cangma Huadu Granules (CMHD) is an in-hospital preparation composed of eight traditional Chinese medicines (TCM), which has been clinically used against COVID-19 in China… read more here.
Keywords: cmhd; expression; p65; coronavirus influenza ... See more keywords
Abstract PO-045: Multiplex analysis of coronavirus and influenza antibodies using the ZIVA multiplex platform
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Cancer Research"
DOI: 10.1158/1557-3265.covid-19-po-045
Abstract: Detection of antibodies to upper respiratory pathogens is critical to surveillance, assessment of the immune status of individuals, vaccine development, and basic biology. The urgent need for antibody detection tools has proven particularly acute in… read more here.
Keywords: detection; coronavirus influenza; coronavirus; ziva ... See more keywords